Regression-Aimed Medicine Elastase(Elazym®)with Emphasis on Ancillary Medication at the Time of PTCA
The Journal of Japan Atherosclerosis Society
doi 10.5551/jat1973.17.1_65
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1989
Authors
Publisher
Japan Atherosclerosis Society